Trial Details
COMPLETEDBasic Information
| Clinical ID | c914 |
|---|---|
| Identifier | NCT01551290 |
| Trial Title | A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Infliximab|DRUG: Placebo |
Participant Information
| Sponsor | Xian-Janssen Pharmaceutical Ltd. |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-12 |
|---|---|
| Primary Completion Date | 2025-03-14 |
| Completion Date | 2025-10-14 |